Immunosurveillance and immunotherapy of tumors by innate immune cells

被引:75
|
作者
Iannello, Alexandre
Thompson, Thornton W.
Ardolino, Michele
Marcus, Assaf
Raulet, David H. [1 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, 489 Life Sci Addit, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
NATURAL-KILLER-CELLS; H-2-DEFICIENT LYMPHOMA VARIANTS; B-ASSOCIATED TRANSCRIPT-3; MULTIPLE-MYELOMA CELLS; NKG2D LIGAND MULT1; NK CELLS; CYTOSOLIC DNA; T-LYMPHOCYTES; UP-REGULATION; ACTIVATING RECEPTOR;
D O I
10.1016/j.coi.2015.11.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Increasing evidence supports a role for innate immune effector cells in tumor surveillance. Natural killer (NK) cells and myeloid cells represent the two main subsets of innate immune cells possessing efficient but quite different tumor suppressive abilities. Here, we describe the germline-encoded NK cell receptors that play a role in suppressing tumor development and describe briefly the cellular pathways leading to the upregulation of their ligands in tumor cells. We also describe mechanisms underlying the elimination of tumor cells by macrophages and a recently characterized mechanism dedicated to sensing cytosolic DNA that is implicated in antitumor immune responses.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 50 条
  • [31] Role of innate immune cells in tumor immunosurveillance: Dendritic cells may promote a stronger antitumor response than macrophages
    Constantinescu, MB
    Phan, JN
    Krutzik, SR
    Miller, LS
    Soriano, TT
    Kim, J
    Sieling, PA
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S131 - S131
  • [33] Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells
    Dadi, S.
    Chhangawala, S.
    Whitlock, B. M.
    Franklin, R. A.
    Luo, C. T.
    Oh, S. A.
    Toure, A.
    Pritykin, Y.
    Huse, M.
    Leslie, C. S.
    Li, M. O.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 498 - 498
  • [34] Cancer Immunosurveillance by Tissue-resident Innate Lymphoid Cells and Innate-like T Cells
    Dadi, Saida
    Chhangawala, Sagar
    Whitlock, Benjamin M.
    Franklin, Ruth A.
    Luo, Chong
    Oh, Soyoung A.
    Toure, Ahmed
    Pritykin, Yuri
    Huse, Morgan
    Leslie, Christina S.
    Li, Ming O.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [35] Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
    Dadi, Saida
    Chhangawala, Sagar
    Whitlock, Benjamin M.
    Franklin, Ruth A.
    Luo, Chong T.
    Oh, Soyoung A.
    Toure, Ahmed
    Pritykin, Yuri
    Huse, Morgan
    Leslie, Christina S.
    Li, Ming O.
    CELL, 2016, 164 (03) : 365 - 377
  • [36] Cancer immunotherapy Re-programming cells of the innate and adaptive immune systems
    Manjili, Masoud H.
    Payne, Kyle K.
    ONCOIMMUNOLOGY, 2012, 1 (02) : 201 - 204
  • [37] Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
    Moynihan, Kelly D.
    Opel, Cary F.
    Szeto, Gregory L.
    Tzeng, Alice
    Zhu, Eric F.
    Engreitz, Jesse M.
    Williams, Robert T.
    Rakhra, Kavya
    Zhang, Michael H.
    Rothschilds, Adrienne M.
    Kumari, Sudha
    Kelly, Ryan L.
    Kwan, Byron H.
    Abraham, Wuhbet
    Hu, Kevin
    Mehta, Naveen K.
    Kauke, Monique J.
    Suh, Heikyung
    Cochran, Jennifer R.
    Lauffenburger, Douglas A.
    Wittrup, K. Dane
    Irvine, Darrell J.
    NATURE MEDICINE, 2016, 22 (12) : 1402 - +
  • [38] Immune Checkpoints and Innate Lymphoid Cells-New Avenues for Cancer Immunotherapy
    Jacquelot, Nicolas
    Ghaedi, Maryam
    Warner, Kathrin
    Chung, Douglas C.
    Crome, Sarah Q.
    Ohashi, Pamela S.
    CANCERS, 2021, 13 (23)
  • [39] Influence of Immunotherapy with Autologous Dendritic Cells on Innate and Adaptive Immune Response in Cancer
    Matias, Bruna F.
    de Oliveira, Tania M.
    Rodrigues, Claudia M.
    Abdalla, Douglas R.
    Montes, Leticia
    Murta, Eddie F. C.
    Michelin, Marcia A.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 165 - 172
  • [40] Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
    Kelly D Moynihan
    Cary F Opel
    Gregory L Szeto
    Alice Tzeng
    Eric F Zhu
    Jesse M Engreitz
    Robert T Williams
    Kavya Rakhra
    Michael H Zhang
    Adrienne M Rothschilds
    Sudha Kumari
    Ryan L Kelly
    Byron H Kwan
    Wuhbet Abraham
    Kevin Hu
    Naveen K Mehta
    Monique J Kauke
    Heikyung Suh
    Jennifer R Cochran
    Douglas A Lauffenburger
    K Dane Wittrup
    Darrell J Irvine
    Nature Medicine, 2016, 22 : 1402 - 1410